TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18487567

Group type: EXPERIMENTAL
Intervention: Local IHC
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: Central IHC
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: Central IHC Allred score
Number of subjects: 776
Study: 15925911

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg orally daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Beclomethasone 400 ug local sprays daily
Number of subjects: 40
Study: 11668230

Group type: EXPERIMENTAL
Intervention: TEP with dissection balloon
Number of subjects: 44

Group type: COMPARATOR
Intervention: TEP without dissection balloon
Number of subjects: 44
Study: 9832000

Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate vaccine (group 1, n = 69)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Meningococcal polysaccharide vaccine (group 2, n = 72)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Hepatitis B virus vaccine (group 3, n = 70)
Number of subjects: 211
Study: 8130046

Group type: COMPARATOR
Intervention: morphine 0.15 mg kg‐1 and metoclopramide 10 mg
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: morphine 0.15 mg kg‐1 and glycopyrronium 5 micrograms kg‐1
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: morphine 0.15 mg kg‐1 and hyoscine 5 micrograms kg‐1
Number of subjects: 225
Study: 2604925

Group type: EXPERIMENTAL
Intervention: Self-hypnosis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Children with visible physical disability
Number of subjects: 22
Study: 29431140

Group type: EXPERIMENTAL
Intervention: Novel task-specific centre-based group programme
Number of subjects: 60

Group type: COMPARATOR
Intervention: Parent-led home-based programme
Number of subjects: 60
Study: 26733277

Group type: EXPERIMENTAL
Intervention: Aripiprazole (initial dose 5-10 mg per day followed by flexible doses 5-15 mg per day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Risperidone (initial dose 2-4 mg per day followed by flexible doses 4-6 mg per day)
Number of subjects: 42
Study: 25184356

Group type: EXPERIMENTAL
Intervention: Sapropterin 200 to 400 mg BID
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Sapropterin
Number of subjects: 61
Study: 20634016

Group type: EXPERIMENTAL
Intervention: Hands-only CPR (HO-CPR)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard CPR (STD-CPR)
Number of subjects: 17
Study: 20005545

Group type: EXPERIMENTAL
Intervention: Hyperoxia at rest
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperoxia after handgrip
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of hyperoxia and handgrip
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normoxic condition handgrip
Number of subjects: 0
Study: 17574795

Group type: EXPERIMENTAL
Intervention: Modified therapeutic community (TC) track with psychoeducational seminar, trauma-informed addictions treatment, and case management
Number of subjects: 34

Group type: COMPARATOR
Intervention: Basic program services (Control group)
Number of subjects: 34
Study: 15748090

Group type: EXPERIMENTAL
Intervention: Escitalopram 10-20 mg/day
Number of subjects: 251

Group type: COMPARATOR
Intervention: Venlafaxine 75-150 mg/day
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 251

Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 251
Study: 11262776

Group type: EXPERIMENTAL
Intervention: Reconstructive procedures in surgical treatment of tumors
Number of subjects: 56
Study: 9715201

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX) 80 mg/400 mg orally three times daily for 10 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7978398

Group type: EXPERIMENTAL
Intervention: 1 mg ondansetron
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron
Number of subjects: 589

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 589
Study: 2648609

Group type: EXPERIMENTAL
Intervention: Tear solution with polyvinyl alcohol 1.4% m/v preserved with 0.5% m/v chlorobutanol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Tear solutions without chlorobutanol
Number of subjects: 16
Study: 31955998

Group type: EXPERIMENTAL
Intervention: 3-dimensional fluoroscopy
Number of subjects: 206

Group type: COMPARATOR
Intervention: 2-dimensional fluoroscopy
Number of subjects: 206
Study: 27862715

Group type: EXPERIMENTAL
Intervention: CRT=ON
Number of subjects: 328

Group type: COMPARATOR
Intervention: CRT=OFF
Number of subjects: 328
Study: 25955086

Group type: EXPERIMENTAL
Intervention: PCM Cervical Disc
Number of subjects: 293

Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 293
Study: 23952854

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 662
Study: 21849377

Group type: EXPERIMENTAL
Intervention: Individually adjusted, progressive and specific balance group training, three times a week for three months
Number of subjects: 59
Study: 19935020

Group type: EXPERIMENTAL
Intervention: 21/7-day norgestimate/ethinyl E2 25-microgram OCP
Number of subjects: 332

Group type: COMPARATOR
Intervention: 24/4-day drospirenone/ethinyl E2 20-microgram OCP
Number of subjects: 332
Study: 17241751

Group type: EXPERIMENTAL
Intervention: 68 Gy
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: 68-78 Gy to the SVs
Number of subjects: 549
Study: 15542065

Group type: EXPERIMENTAL
Intervention: Platelets from NIDDM patients in a medium containing 180 mg/dL glucose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platelets from NIDDM patients in a medium containing 90 mg/dL glucose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control platelets
Number of subjects: 0
Study: 11359198

Group type: EXPERIMENTAL
Intervention: Anticholinesterasic pesticides exposure (measured by AChE and BChE levels)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Social-economic factors (educational level)
Number of subjects: 55
Study: 9573749

Group type: COMPARATOR
Intervention: Standard-size cuff (RCS)
Number of subjects: 1791

Group type: EXPERIMENTAL
Intervention: Large-size cuff (LCS)
Number of subjects: 1791

Group type: EXPERIMENTAL
Intervention: Android obesity (LCS subgroup)
Number of subjects: 1791

Group type: EXPERIMENTAL
Intervention: Gynoid obesity (LCS subgroup)
Number of subjects: 1791
Study: 8158885

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control (other antihypertensive treatments excluding ACE inhibitors)
Number of subjects: 121
Study: 30232856

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (puncturing specific acupoints with filiform needles, once every other day for 8 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Medication treatment (Omeprazole capsules, 20 mg twice a day for 8 weeks)
Number of subjects: 58
Study: 27632953

Group type: EXPERIMENTAL
Intervention: Anterior approach (AA) for hepatectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional approach (CA) for hepatectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anterior approach (AA) for hepatectomy in patients with large-size tumor (>5 cm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional approach (CA) for hepatectomy in patients with large-size tumor (>5 cm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anterior approach (AA) for hepatectomy in patients with small-size tumor (≤5 cm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional approach (CA) for hepatectomy in patients with small-size tumor (≤5 cm)
Number of subjects: 0
Study: 25321941

Group type: EXPERIMENTAL
Intervention: LipiFlow (automated thermodynamic treatment)
Number of subjects: 26
Study: 22386977

Group type: EXPERIMENTAL
Intervention: Whole body vibration training program (8 weeks, 3 times a week on a vibration platform)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (home-based physical therapy program without vibration training)
Number of subjects: 31
Study: 20143872

Group type: EXPERIMENTAL
Intervention: 1.2 mg of folic acid daily for 12 weeks
Number of subjects: 0
Study: 18317323

Group type: EXPERIMENTAL
Intervention: Lower-fidelity simulation
Number of subjects: 0
Study: 16573801

Group type: EXPERIMENTAL
Intervention: Lansoprazole 90 mg, 6 mg/h
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lansoprazole orally disintegrating tablet 60 mg every 6 h
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lansoprazole 120 mg, 9 mg/h
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lansoprazole 120 mg, 6 mg/h
Number of subjects: 36
Study: 14523765

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine
Number of subjects: 100
Study: 10808678

Group type: EXPERIMENTAL
Intervention: Primary amenorrhea patients
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Secondary amenorrhea patients
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (regularly menstruating women)
Number of subjects: 36
Study: 8765377

Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: metoclopramide
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: cisapride
Number of subjects: 426

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 426
Study: 1558237

Group type: EXPERIMENTAL
Intervention: Early active motion
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Continuous passive motion
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combination of both early active motion and continuous passive motion
Number of subjects: 75
Study: 2868941

Group type: EXPERIMENTAL
Intervention: Cesarean section
Number of subjects: 41

Group type: COMPARATOR
Intervention: Vaginal delivery
Number of subjects: 41
Study: 30621692

Group type: EXPERIMENTAL
Intervention: Participants of ISRT (cases)
Number of subjects: 1208

Group type: COMPARATOR
Intervention: Non-participants (controls)
Number of subjects: 1208
Study: 30105459

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27286745

Group type: EXPERIMENTAL
Intervention: Vaporized cannabis (2.9% delta 9-THC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Vaporized cannabis (6.7% delta 9-THC)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 24361229

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with assessment of response at week 12 using anatomic imaging (CT/MRI)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with assessment of response at week 12
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with assessment of response at week 12 for ERMS
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with assessment of response at week 12 for ARMS
Number of subjects: 338
Study: 22697080

Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline (HS) with epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (NS) with epinephrine
Number of subjects: 0
Study: 20831697

Group type: EXPERIMENTAL
Intervention: Bath PUVA
Number of subjects: 34

Group type: COMPARATOR
Intervention: NB-UVB
Number of subjects: 34
Study: 17350688

Group type: EXPERIMENTAL
Intervention: Femtosecond laser (IntraLase FS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Mechanical microkeratome (Hansatome)
Number of subjects: 21
Study: 16376766

Group type: EXPERIMENTAL
Intervention: Biphasic response during dipyridamole echocardiography test (DET)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sustained improvement in regional contractility
Number of subjects: 80

Group type: COMPARATOR
Intervention: No change in contractility
Number of subjects: 80

Group type: COMPARATOR
Intervention: Worsening response
Number of subjects: 80
Study: 16579082

Group type: EXPERIMENTAL
Intervention: Jian Nao Ning (JNN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: duxil
Number of subjects: 40
Study: 9854467

Group type: EXPERIMENTAL
Intervention: Butyrate enemas
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline enemas
Number of subjects: 10
Study: 7611002

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A (BOTOX) 0.5 U/site
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A (BOTOX) 1.25 U/site
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A (BOTOX) 2.5 U/site
Number of subjects: 0
Study: 2230552

Group type: EXPERIMENTAL
Intervention: Goode T-tube
Number of subjects: 15

Group type: COMPARATOR
Intervention: Armstrong tube
Number of subjects: 15
Study: 646600

Group type: EXPERIMENTAL
Intervention: Videotape immediate feedback during rehabilitation sessions (four sessions at weekly intervals)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (videotaped but did not view tapes or discuss performances)
Number of subjects: 12
Study: 31852491

Group type: EXPERIMENTAL
Intervention: AutoKinetics
Number of subjects: 336

Group type: COMPARATOR
Intervention: Standard dosing (Control)
Number of subjects: 336
Study: 27883997

Group type: EXPERIMENTAL
Intervention: CBT4BN (Internet-based manualized CBT group therapy)
Number of subjects: 179

Group type: COMPARATOR
Intervention: CBTF2F (traditional face-to-face group therapy)
Number of subjects: 179
Study: 25827507

Group type: EXPERIMENTAL
Intervention: Low-dose lithium added to optimized treatment (OPT)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Optimized treatment (OPT) alone
Number of subjects: 283
Study: 23387340

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane (TAP) block
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Wound infiltration
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 21029208

Group type: EXPERIMENTAL
Intervention: synchronous balneophototherapy (sBPT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: narrow-band UVB monotherapy (PT)
Number of subjects: 180
Study: 19899672

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic treatment using empatho-techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 0
Study: 16964862

Group type: EXPERIMENTAL
Intervention: MIRD formula‐based dosimetric method
Number of subjects: 89

Group type: COMPARATOR
Intervention: Fixed-lambda(eff) method
Number of subjects: 89
Study: 12934418

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 128

Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Age over 50
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 128
Study: 11014095

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study: 9089983

Group type: EXPERIMENTAL
Intervention: Single donor platelet‐pheresis products (SD‐PC)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Platelets made from pooled buffy coats (BC‐PC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Pooled units of platelets made by the platelet‐rich plasma method (PRP‐PC)
Number of subjects: 51
Study: 8196254

Group type: EXPERIMENTAL
Intervention: Digoxin (35 mg/day)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Captopril (0.31 mg/day)
Number of subjects: 22
Study: 3529832

Group type: EXPERIMENTAL
Intervention: Chlormethiazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 0
Study: 30904707

Group type: EXPERIMENTAL
Intervention: Psych group (patients with pre-existing psychiatric diagnoses)
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Non-psych group (patients without pre-existing psychiatric diagnoses)
Number of subjects: 1275
Study: 28095971

Group type: EXPERIMENTAL
Intervention: Undiagnosed severe obstructive sleep apnea (apnea-hypopnea index ≥ 30 events/h)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Individuals with OSA and excessive daytime sleepiness (Epworth Sleepiness Scale score of 10 or higher)
Number of subjects: 788
Study: 26204531

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow mononuclear cell intracoronary transplantation (mean dose of 8.19 ± 4.43 x 10(6) CD34+ cells)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 23
Study: 22834764

Group type: EXPERIMENTAL
Intervention: Social support from social network and nurses
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 164
Study: 22049165

Group type: EXPERIMENTAL
Intervention: Graded intakes of protein (0.1-2.56 g · kg(‐1) · d(‐1))
Number of subjects: 7

Group type: COMPARATOR
Intervention: Current DRI recommendations for protein (0.76 g · kg(‐1) · d(‐1))
Number of subjects: 7
Study: 19892301

Group type: EXPERIMENTAL
Intervention: Ivermectin 200 microg/kg/day for 2 days, repeated within 2 weeks, every 6 months if persisting immunosuppression
Number of subjects: 0
Study: 16537862

Group type: EXPERIMENTAL
Intervention: aCPAP (autoadjusted continuous positive airway pressure)
Number of subjects: 30

Group type: COMPARATOR
Intervention: cCPAP (constant continuous positive airway pressure)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Preference
Number of subjects: 30
Study: 15253822

Group type: EXPERIMENTAL
Intervention: Acucise endopyelotomy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Hynes‐Anderson pyeloplasty
Number of subjects: 22
Study: 11315476

Group type: EXPERIMENTAL
Intervention: Digital radiography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-developing film
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manually processed film
Number of subjects: 0

Group type: COMPARATOR
Intervention: Film developed in an automatic processor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Digital images on a liquid crystal diode
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Digital images on a cathode ray tube screen
Number of subjects: 0
Study: 9160991

Group type: EXPERIMENTAL
Intervention: Exculpatory clauses present in the contract
Number of subjects: 101

Group type: COMPARATOR
Intervention: Exculpatory clauses not present in the contract
Number of subjects: 101
Study: 7957448

Group type: EXPERIMENTAL
Intervention: MSP (20 mg base of mefloquine/kg body weight)
Number of subjects: 23

Group type: COMPARATOR
Intervention: MSP plus primaquine (0.75 mg/kg)
Number of subjects: 23
Study: 3069760

Group type: EXPERIMENTAL
Intervention: sulconazole nitrate 1% cream applied twice daily for 14 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: miconazole nitrate 2% cream applied twice daily for 14 days
Number of subjects: 80
Study: 29053851

Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/d
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28622034

Group type: EXPERIMENTAL
Intervention: mHealth intervention (bi-directional text messaging via SMS, WhatsApp, and Facebook) for 12 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: mHealth intervention (bi-directional text messaging)
Number of subjects: 40
Study: 25756419

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33°C
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 36°C
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Procalcitonin levels
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Interleukin‐6 levels
Number of subjects: 169
Study: 23187936

Group type: EXPERIMENTAL
Intervention: MVC 150 mg once daily
Number of subjects: 121

Group type: COMPARATOR
Intervention: TDF/FTC 300/200 mg once daily + ATV/r 300/100 mg once daily
Number of subjects: 121
Study: 22328095

Group type: EXPERIMENTAL
Intervention: Janthinobacterium lividum treatment
Number of subjects: 0
Study: 19506932

Group type: EXPERIMENTAL
Intervention: Fatty Fish (FF) diet (4.3 portions of fish per week)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Lean Fish (LF) diet (4.7 portions of fish per week)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control diet (0.6 portions of fish per week)
Number of subjects: 27
Study: 16284083

Group type: EXPERIMENTAL
Intervention: 17beta-estradiol supplementation (ES; 2 mg/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PL; glucose polymer)
Number of subjects: 11
Study: 15331898

Group type: EXPERIMENTAL
Intervention: TURP
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser treatment (contact and hybrid)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 98
Study: 10647524

Group type: EXPERIMENTAL
Intervention: New modified configuration
Number of subjects: 36

Group type: COMPARATOR
Intervention: Original Ma-Griffith configuration
Number of subjects: 36
Study: 9497875

Group type: EXPERIMENTAL
Intervention: IGF‐I infusion (43.7 pmol/kg/min or 20 micrograms/kg/h)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Insulin infusion (3.4 pmol/kg/min or 0.5 mU/kg/min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Insulin infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: IGF‐I infusion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: IGF‐I and insulin infusions
Number of subjects: 6
Study: 8298916

Group type: EXPERIMENTAL
Intervention: Patch angioplasty
Number of subjects: 213

Group type: COMPARATOR
Intervention: No patch angioplasty (Control)
Number of subjects: 213
Study: 3674248

Group type: EXPERIMENTAL
Intervention: Community Care Program (foster home care)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Nursing home care
Number of subjects: 112
Study: 29081326

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) exposure therapy, approximately 1 hour
Number of subjects: 36

Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR) and psychoeducation, approximately 30 minutes of PMR and 15 minutes of psychoeducation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both VR and PMR groups
Number of subjects: 36
Study: 26635305

Group type: EXPERIMENTAL
Intervention: Higher level of amino acids (1.2 g/kg)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard amino acid intake (0.8 g/kg)
Number of subjects: 119
Study: 25465451

Group type: EXPERIMENTAL
Intervention: Oral discussion and written handout outlining the risks of otoplasty
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional oral dialog of the surgical risks
Number of subjects: 50
Study: 23419912

Group type: EXPERIMENTAL
Intervention: Radial nerve mobilisation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non‐therapeutic dose of intermittent ultrasound
Number of subjects: 60